South Korea implements product pre-approval regulation

in-text-44861 — New OTC derivatives will need approval

Richard Jory
Rebecca Hampson
01 Jul 2010

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

South Korea’s new derivatives testing system came into effect on June 13 in a bid to counter the bankruptcy of many small firms resulting from risky investments in foreign exchange derivatives during the financial crisis.

The New Product Approval (NPA) system requires financial investment companies, such as investment dealers and investment brokers, to receive pre-approval from the Korean Financial Investment Association (Kofia) for new over-the-counter derivatives. Korea is the first country to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]